Ryan Neely, PhD

Why follow Ryan

Ryan Neely is Co-founder and CEO at Skribe Medical. Skribe Medical announced its selection for the FDA READI-Home innovation program in a November 11, 2026 release. It is developing wearable cardiac assessment for people receiving cancer treatment. Program participation is not FDA marketing authorization. The release discloses a previously raised $1.65 million pre-seed round led by SeaX Ventures with GoAhead Ventures and Marin Sonoma Impact Ventures. November 11 is the disclosure date, not a verified date of a new financing close. Ryan Neely, PhD is co-founder and CEO.